2019 Medicinal Chemistry Reviews

New Progress in Protease-Activated Receptor 1 and 4 (Par-1 and Par-4) Antagonists as Antiplatelet Therapy for Treatment Cardiovascular Disease.
Xiaojun Zhang

Ref. n°: REV2019-ch3

You must be connected to be able to download the pdf file of this chapter.